Purchases and Sales Made in Q2 2022 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q2 2022. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 15, 2022
Q2 2022
|
Bvf Inc
San Francisco, CA |
BUY
|
- |
21.8MNew |
$102M - $288M
|
21.8M
$1.13B
|
|
Aug 15, 2022
Q2 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
6.07MNew |
$28.4M - $80.4M
|
6.07M
$316M
|
|
Aug 15, 2022
Q2 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
BUY
|
- |
1MNew |
$4.69M - $13.3M
|
1M
$52.2M
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
BUY
|
- |
871KNew |
$4.08M - $11.5M
|
871K
$45.4M
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
742KNew |
$3.48M - $9.83M
|
742K
$38.7M
|
|
Aug 15, 2022
Q2 2022
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
500KNew |
$2.35M - $6.63M
|
500K
$26.1M
|
|
Aug 15, 2022
Q2 2022
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
- |
432KNew |
$2.03M - $5.72M
|
432K
$22.5M
|
|
Aug 15, 2022
Q2 2022
|
Tang Capital Management LLC
San Diego, CA |
BUY
|
- |
319KNew |
$1.5M - $4.23M
|
319K
$16.6M
|
|
Aug 15, 2022
Q2 2022
|
Ghost Tree Capital, LLC
New York, NY |
BUY
|
- |
300KNew |
$1.41M - $3.98M
|
300K
$15.7M
|
|
Aug 12, 2022
Q2 2022
|
Monashee Investment Management LLC
Boston, MA |
BUY
|
- |
200KNew |
$938K - $2.65M
|
200K
$10.4M
|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
BUY
|
- |
159KNew |
$746K - $2.11M
|
159K
$8.3M
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
73.7KNew |
$345K - $976K
|
73.7K
$3.84M
|
|
Aug 11, 2022
Q2 2022
|
Alps Advisors Inc
Denver, CO |
BUY
|
- |
31.3KNew |
$147K - $414K
|
31.3K
$1.63M
|
|
Aug 04, 2022
Q2 2022
|
Td Asset Management Inc
|
BUY
|
- |
29KNew |
$136K - $384K
|
29K
$1.51M
|
|
Aug 05, 2022
Q2 2022
|
Meridian Wealth Management, LLC
|
BUY
|
- |
27KNew |
$127K - $358K
|
27K
$1.41M
|
|
Aug 05, 2022
Q2 2022
|
Cowen And Company, LLC
|
BUY
|
- |
16.2KNew |
$75.9K - $214K
|
16.2K
$844K
|
|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
15.1KNew |
$70.7K - $200K
|
15.1K
$787K
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
11.8KNew |
$55.3K - $156K
|
11.8K
$615K
|
|
Aug 15, 2022
Q2 2022
|
Penserra Capital Management LLC
Orinda, CA |
BUY
|
- |
3.2KNew |
$15K - $42.3K
|
3.2K
$167K
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
25New |
$117 - $331
|
25
$1.3K
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-139K- 92.2% |
$654K - $1.85M
|
11.8K
$615K
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-654KClosed |
$3.07M - $8.66M
|
0
$0
|